Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 7:08 PM ET

Capital Markets

Company Overview of TVS Capital Funds Limited

Company Overview

TVS Capital Funds Limited is a private equity and venture capital arm of TV Sundram Iyengar and Sons Limited specializing in early growth to late-stage, Pre-IPO, PIPE, buy-outs, carve-outs, synthetic start-ups, and mezzanine investments. The firm seeks to invest in private companies, listed and unlisted companies, and in mid-cap, family-owned businesses. The firm invests in emerging sectors and in opportunities that are not 'core' but where the investible attractiveness is high such as Pre IPO and PIPE opportunities with a clear visibility for liquidity events or significant minority in unlisted companies. It prefers to invest in consumer companies, communication, footwear, social infrastruc...

249 A, Ambujammal Street

Off TTK Road

Alwarpet

Chennai,  600018

India

Founded in 2007

Phone:

91 44 4295 4800

Fax:

91 44 4295 4888

Key Executives for TVS Capital Funds Limited

Founder, Chief Executive Officer, Managing Director, and Chairman
Age: 57
Chief Financial Officer and Executive Director
Age: 59
Chief Operating Officer and Executive Director
Managing Director and Vice Chairman
Age: 71
Director of Investments, Head of Pipe and Pre-IPO
Compensation as of Fiscal Year 2015.

TVS Capital Funds Limited Key Developments

MedPlus Health Services Reportedly Up For Sale

MedPlus Health Services Pvt. Ltd. has reportedly restarted talks for a possible sell-off. General Atlantic LLC and Bain Capital, LLC are in discussions to acquire the business. Three PE investors together hold 69% stake in MedPlus while Madhukar Gangadi, Founder and Chief Executive Officer, MedPlus, holds the rest. The existing investors, Mount Kellett Capital Management LP, TVS Capital Funds Limited and Ajay Piramal’s India Ventures Advisors I, put their stake on the block sometime back. Of the 69% stake held by investors, Mount Kellett holds 49% through its arm MKCP Direct Investments (Mauritius) IV Ltd, TVS Capital’s TVS Shriram Growth Fund I holds 10.59% and India Venture Advisors' India Venture Trust Fund-I holds 9.09%, according to a company balance sheet. MedPlus is looking at a valuation of INR 25 billion. Credit Suisse Group AG (SWX:CSGN) is advising MedPlus Health Services on the sale process.

Owners And Investors Reportedly Plan To Exit Dusters Total Solutions

Investors and promoters of Dusters Total Solutions Services Pvt Ltd. (company) have put up the company on sale. The company, which is backed by TVS Capital Funds Limited, is being valued at $45-$50 million, said three people with direct knowledge of the development. "The promoters and investors want to exit the business. They have begun talk with strategic investors in the space," said a person involved in the deal. "If the price offered is right, even the promoters will exit, otherwise only TVS may sell its stake."Since TVS has stayed its course in the company, it wants to exit. There is a lot of strategic interest in this space," said another person with knowledge of the deal.

MedPlus Health Services Reportedly Up For Sale

MedPlus Health Services Pvt. Ltd. reportedly is up for sale. Madhukar Gangadi, Founder and Chief Executive Officer of MedPlus Health Services, along with a clutch of private equity investors including Mount Kellett Capital Management LP, TVS Capital Funds Limited and India Venture Advisors have put MedPlus Health Services up for sale. Credit Suisse Group AG (SWX:CSGN) has been appointed to look for strategic buyers and buyout funds who can acquire a controlling 51% to 74% stake in the Hyderabad headquartered chain. Medplus was earlier looking to raise fresh capital but now the mandate has changed to a potential outright sale, one of the sources mentioned above said. Source added, domestic players and buyout funds have already been approached. "The investors want to exit. There will be some primary issuance of equity as well. After this the promoter's stake will come down to around 26%," another person aware of the developments said. With revenues of around INR 12 billion to INR 13 billion, the investors and promoters are expecting a significant premium of two times sales, valuing the company at around INR 27 billion, said three persons with direct knowledge of the matter. The company management has decided not to respond to the queries. Madhukar Gangadi too did not want to respond.

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
October 27, 2015
Indian Energy Exchange Limited
Merger/Acquisition
September 7, 2015
Indian Energy Exchange Limited
Private Placement
August 31, 2015
FSN Ecommerce Ventures Pvt. Ltd.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TVS Capital Funds Limited, please visit www.tvscapital.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.